Angiosarcoma of the Prostate Gland following Brachytherapy for Prostatic Adenocarcinoma

Abstract

Prostatic adenocarcinoma is the most common cancer in men, but only a handful of cases of prostatic angiosarcoma have been reported in the literature. Prior radiation therapy for prostatic adenocarcinoma has been hypothesized to be a risk factor for angiosarcoma. The increasing practice of prostate cancer screening and the use of radiation therapy for management of prostatic adenocarcinoma will likely lead to more cases of prostatic angiosarcoma. Diagnosis is made by tissue sampling. Optimal management of these aggressive tumors remains to be defined and outcomes are poor with a high 1-year mortality. Primary care physicians and urologists should be aware of this rare entity and refer these patients to specialist centers where they can be managed by a multidisciplinary team. We report a case of angiosarcoma of the prostate gland diagnosed in a male presenting with lower urinary tract symptoms 5 years after brachytherapy for prostate adenocarcinoma.

Primary splenic angiosarcoma: a diagnostic enigma

“…3 Exposure to radiation and chemicals like thorium, arsenic, vinyl chloride are considered for risk factors of angiosarcoma. 9 Few authors have concluded that PSA may be result of malignant transformation of other benign splenic tumors like hemangiomas, lymphangiomas and hemangioendotheliomas. 2,3,8,10,11 The most common symptom in patients with PSA is abdominal pain.…”

Primary Angiosarcoma of the Spleen: Rare Diagnosis with Atypical Clinical Course

“…Exposure to radiation and lymphedema [5] and exposure to chemicals such as thorium, arsenic, and vinyl chloride are mostly recognized risk factors of angiosarcoma [6]. Retrospective study of Fayette et al [5] showed that breast angiosarcoma contributes by 35% to all angiosarcomas.…”